Solid tumor Clinical Trials in Scottsdale, AZ
As of September 2026, 35 paid clinical trials are recruiting for Solid tumor in Scottsdale, Arizona. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Scottsdale
Filter results
Newly added in Scottsdale
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
36 clinical trials for Solid tumor
·Clear filters·FOG-001 in Locally Advanced or Metastatic Solid Tumors
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
A Study of PYX-201 in Advanced Solid Tumors
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmocodynamics and Preliminary Antitumor Activity of AT-1965 in Patients With Advanced, Refractory or Recurrent Solid Tumors
SW-682 in Advanced Solid Tumors
A Study to Test the Safety and Tolerability of SBO-154 in Patients With Advanced Solid Tumors.
A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
Study of DT-7012 as a Single Agent and in Combination With an Immune Checkpoint Inhibitor in Participants With Advanced Solid Tumors
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
A Study of KK2269 in Adult Participants With Solid Tumors
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
Trial to Evaluate Safety, PD & PK of IV Study Drug, QN-302, in Pts w/ Advanced or Metastatic Solid Tumors
Educational Tools for the Improvement of Early Advance Care Planning in Adolescents and Young Adults With Advanced Solid Tumors and High-Grade Brain Tumors
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Biomarkers to Predict Cancer Therapy-related Cardiotoxicity
Investigating Memory and Physical Activity After Cancer Treatment in Survivors of Adolescent and Young Adult Cancers
Genetic Testing for the Prevention of Cancer in American Indian Communities (JUNIPER Trial)
Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning
Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer
Virtual Art Therapy Assisted Re-Integration to Improve Biopsychosocial Outcomes in Adolescent and Young Adult Cancer Survivors, AVATARS Trial
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
A Collaborative Intervention for Improving Cancer Pain Management in Cancer Survivors
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
Cancer Genetic Testing in Ethnic Populations
Group Curriculum for Improving Survivorship Outcomes in Adolescent and Young Adult Cancer Survivors
A Study of SPX-303, a Bispecific Antibody Targeting LILRB2 and PD-L1 in Patients With Solid Tumors
A Trial to Investigate the Safety of E303 in Participants With Advanced Refractory Solid Tumors
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Top Research Study Locations in Scottsdale
Researchers run research studies in Scottsdale, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Mayo Clinic in Arizona | Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm, Hematopoietic and Lymphoid System Neoplasm | 88 |
| Mayo Clinic Arizona | Crohn Disease, Healthy, Ulcerative Colitis | 28 |
| Mayo Clinic | Breast Cancer, Colorectal Neoplasms, Hidradenitis Suppurativa | 24 |
| HonorHealth Research Institute | Advanced Solid Tumor, Solid Tumor, Colorectal Cancer | 21 |
| HonorHealth | Hypertension, Advanced Prostate Cancer, Advanced Solid Tumors | 14 |
| Honor Health Research Institute | Non-Hodgkin Lymphoma, Advanced Cancer, Advanced Prostate Cancer | 13 |
| Honor Health | Adamantinomatous Craniopharyngioma, Advanced Metastatic Castration Resistant Prostate Cancer, Advanced Solid Tumors | 12 |
| Headlands Research - Scottsdale | Obesity, Overweight, Alcohol Use Disorder | 7 |
| Scottsdale Clinical Trials | Diabetic Peripheral Neuropathic Pain, Celiac Disease, Diabetes Mellitus, Type 2 | 6 |
| Ironwood Cancer & Research Centers | Advanced Non-Small Cell Lung Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| Research Network Arizona | Macular Edema Secondary to Inflammation, Diabetic Macular Edema, Geographic Atrophy Secondary to Age-related Macular Degeneration | 5 |
| HonorHealth Research and Innovation Institute | Active Refractory Rheumatoid Arthritis, Advanced Solid Tumor, CRC | 4 |
| Arizona Center for Cancer Care - Scottsdale | Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 | 3 |
| HonorHealth Neurology | Acute Ischemic Stroke, Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP), Degenerative Lumbar Disc Disease | 3 |
| HonorHealth Research & Innovation Institute | ASCVD, Aortic Valve Disease Mixed, Aortic Valve Regurgitation | 3 |
| Mayo Clinic - Scottsdale | Angiosarcoma, Breast Cancer, Breast Neoplasms | 3 |
| Mayo Clinic Scottsdale | Lung Cancer, Amyotrophic Lateral Sclerosis (ALS), Brain Tumor | 3 |
| Mayo Clinic in Arizona - Scottsdale | Crohn Disease, Myositis, Ulcerative Colitis | 3 |
| Retina Macula Institute of Arizona | Age-related Macular Degeneration (AMD), DME, Diabetic Macular Edema | 3 |
| Vincere Cancer Center | Cancer | 3 |
| GSK Investigational Site | Irritable Bowel Syndrome, Scleroderma, Systemic, Systemic Sclerosis Associated Interstitial Lung Disease | 2 |
| Clinical Trial Site | Generalized Myasthenia Gravis, Lichen Planopilaris | 2 |
| Honor Health Research and Innovation Institute | Leiomyosarcomas, Long QT Syndrome (LQTS) 2, Non-Small Cell Lung Cancer | 2 |
| HonorHealth Scottsdale Osborn Medical Center | Glioblastoma, LE ALI, Lower Extremity Acute Limb Ischemia | 2 |
| Imaging Endpoints | Alzheimer Disease, Agitation | 2 |
Active & Upcoming Studies in Scottsdale (2026)
Recruiting trials in Scottsdale grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (127 active studies)
- A Physical Activity Program Compared to Health Education for Improving Memory and Attention in Hispanic Women With Newly-Diagnosed Stage I-IIIa Breast Cancer, MAMA Trial · Mayo Clinic
- A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors · Phase 1 · Cogent Biosciences, Inc.
Neurology & pain (25 active studies)
- A Study of TAK-755 in Adults With Acute Ischemic Stroke · Phase 2 · Takeda
- A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis · Phase 3 · Zenas BioPharma (USA), LLC
Cardiovascular (16 active studies)
Diabetes & metabolic (12 active studies)
- Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities · Phase 2 · AbbVie
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
Eye & vision (11 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002) · Phase 2, Phase 3 · EyeBiotech Ltd.
Vaccines (3 active studies)
Mental health & behavior (2 active studies)
- Senyo Health With Substance Use Disorder (SUD) in Primary Care · Mayo Clinic
- Native Spirit: Significant Aim 3: Intervention · Arizona State University
Pediatric (1 active study)
- Randomized Study in Children and Adolescents With Migraine: Acute Treatment · Phase 3 · Pfizer
Common conditions studied in Scottsdale
- Malignant Solid Neoplasm (14 active studies)
- Hematopoietic and Lymphatic System Neoplasm (12 active studies)
- Advanced Solid Tumor (9 active studies)
- Cancer (9 active studies)
- Breast Cancer (8 active studies)
- Solid Tumor (8 active studies)
Leading research sponsors in Scottsdale
- Mayo Clinic
- Eli Lilly and Company
- Pfizer
- Sanofi
- Boehringer Ingelheim
Frequently asked questions
How many paid clinical trials are currently recruiting in Scottsdale?
There are approximately 385 recruiting clinical trials in Scottsdale, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Scottsdale pay participants?
Most recruiting trials in Scottsdale compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Scottsdale?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Scottsdale?
The most common conditions under active study in Scottsdale include Malignant Solid Neoplasm (14), Hematopoietic and Lymphatic System Neoplasm (12), Advanced Solid Tumor (9), Cancer (9), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Scottsdale?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Scottsdale on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Scottsdale?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Scottsdale?
Recruiting research sites in Scottsdale include Mayo Clinic in Arizona, Mayo Clinic Arizona, Mayo Clinic, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Scottsdale right now?
The largest active categories in Scottsdale are Cancer & tumors (127), Neurology & pain (25), Cardiovascular (16). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.